Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies

Jack P Antel, Veronique E Miron

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

To review the direct and indirect effects on the central nervous system (CNS) of systemically administered immuno-modulatory therapies in use or under evaluation for the relapsing forms of multiple sclerosis (MS).
Original languageEnglish
Pages (from-to)951-7
Number of pages7
JournalClinical Neurology and Neurosurgery
Volume110
Issue number9
DOIs
Publication statusPublished - Nov 2008

Keywords / Materials (for Non-textual outputs)

  • Animals
  • Multiple Sclerosis
  • Recombinant Proteins
  • Antineoplastic Agents
  • Humans
  • Interferon Type I
  • Peptides
  • Propylene Glycols
  • Sphingosine
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Central Nervous System
  • Immunosuppressive Agents

Fingerprint

Dive into the research topics of 'Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies'. Together they form a unique fingerprint.

Cite this